Table 3.
Quality Indicator | Cancer Study Population | Qualified Study Sample (No. of patients) | Days |
|||
---|---|---|---|---|---|---|
Mean | SD | Median | IQR | |||
Days from diagnosis to initiation of initiation of treatment (i.e. surgery, chemotherapy, and/or radiation therapy) | Stages II and III colorectal cancer | 1,729 | 26.6 | 38.2 | 20.0 | 37 |
Days from definitive surgical resection to start of adjuvant chemotherapy | Stages II and III colorectal cancer | 767 | 64.9 | 54.9 | 50.0 | 35 |
Days from definitive surgical resection to surveillance colonoscopy for colonoscopies performed at least 7 months after surgical resection | Stages I, II, and III colorectal cancer with no preoperative obstructing lesion documented | 644 | 444.1 | 182.1 | 393.0 | 166 |
Abbreviation: IQR, interquartile range.